Neonc Technologies Holdings, Inc. SEC filings NTHI

Neonc Technologies Holdings, Inc. has 208 filings in SEC EDGAR's recent list, going back to Jun 22, 2023. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Neonc Technologies Holdings, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
8-K Current report
Regulation FD disclosure
Nov 3, 2026 Nov 2, 2026
8-K Current report
Regulation FD disclosure
Oct 22, 2026 Oct 16, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 15, 2026 Oct 9, 2026
8-K Current report
Regulation FD disclosure
Sep 28, 2026 Sep 28, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 21, 2026 Sep 15, 2026
8-K Current report
Regulation FD disclosure
Sep 17, 2026 Sep 16, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Sep 10, 2026 Sep 8, 2026
8-K/A Amended current report
Officer or director change
Aug 21, 2026 Jun 27, 2026
8-K Current report
Shareholder vote results
Aug 20, 2026 Aug 14, 2026
8-K Current report
Regulation FD disclosure
Aug 13, 2026 Aug 12, 2026
8-K Current report
Regulation FD disclosure
Aug 12, 2026 Aug 12, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 10, 2026 Aug 10, 2026
8-K Current report
Regulation FD disclosure
Jul 15, 2026 Jul 15, 2026
8-K Current report
Officer or director change
Jul 2, 2026 Jun 27, 2026
8-K Current report
Regulation FD disclosure
Jun 23, 2026 Jun 23, 2026
8-K Current report
Regulation FD disclosure
Jun 18, 2026 Jun 16, 2026
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Jun 12, 2026 Jun 10, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 18, 2026 May 18, 2026
8-K Current report
Material agreement, Unregistered share sale
Apr 24, 2026 Apr 20, 2026
8-K Current report
Regulation FD disclosure
Apr 16, 2026 Apr 14, 2026
8-K Current report
Material agreement
Apr 10, 2026 Apr 10, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Apr 3, 2026 Apr 1, 2026
8-K Current report
Material agreement, Unregistered share sale
Mar 23, 2026 Mar 20, 2026
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Mar 17, 2026 Mar 12, 2026
8-K Current report
Regulation FD disclosure
Mar 6, 2026 Mar 4, 2026
8-K Current report
Other events
Mar 4, 2026 Feb 26, 2026
8-K Current report
Material agreement, Unregistered share sale
Mar 3, 2026 Feb 25, 2026
8-K Current report
Regulation FD disclosure
Feb 27, 2026 Feb 27, 2026
8-K Current report
Material agreement, Unregistered share sale
Jan 29, 2026 Jan 29, 2026
8-K Current report
Regulation FD disclosure
Dec 17, 2025 Dec 15, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 5, 2025 Dec 1, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Nov 14, 2025 Nov 12, 2025
8-K Current report
Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 7, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 6, 2025 Oct 31, 2025
8-K Current report
Regulation FD disclosure
Oct 30, 2025 Oct 28, 2025
8-K Current report
Regulation FD disclosure
Oct 10, 2025 Oct 6, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Oct 9, 2025 Oct 4, 2025
8-K Current report
Regulation FD disclosure
Sep 11, 2025 Sep 10, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Officer or director change, Regulation FD disclosure
Aug 22, 2025 Aug 18, 2025
8-K/A Amended current report
Restatement
Aug 20, 2025 Aug 13, 2025
8-K Current report
Restatement
Aug 18, 2025 Aug 13, 2025
8-K Current report
Regulation FD disclosure
Aug 13, 2025 Aug 7, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 1, 2025 Jul 28, 2025
8-K Current report
Material agreement
Jul 30, 2025 Jul 24, 2025
8-K Current report
Regulation FD disclosure
Jul 25, 2025 Jul 22, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Jul 22, 2025 Jul 16, 2025
8-K Current report
Regulation FD disclosure
Jul 10, 2025 Jul 8, 2025
8-K Current report
Regulation FD disclosure
Jun 12, 2025 Jun 6, 2025
8-K Current report
Material agreement, Officer or director change
Jun 6, 2025 Jun 5, 2025
8-K Current report
Officer or director change
Jun 3, 2025 May 28, 2025
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Apr 11, 2025 Apr 7, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 1, 2025 Mar 26, 2025
8-K Current report
Auditor change
Apr 1, 2025 Mar 31, 2025
8-K Current report
Bylaw or fiscal year change, Other events
Mar 27, 2025 Mar 25, 2025

Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NTHI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Calabasas, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1979414

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.